01/08/2010 - Reviews
ABCC2/Abcc2: a multispecific transporter with dominant excretory functions
K. Jemnitz, K. Heredi-Szabo, L Vereczkey and P. Krajcsi
Drug Metab Rev. 2010 Aug;42(3):402-36.
Abstract
ABCC2/Abcc2 (MRP2/Mrp2) is expressed at major physiological barriers, such as the canalicular membrane of liver cells, kidney proximal tubule epithelial cells, enterocytes of the small and large intestine, and syncytiotrophoblast of the placenta. ABCC2/Abcc2 always localizes in the apical membranes. Although ABCC2/Abcc2 transports a variety of amphiphilic anions that belong to different classes of molecules, such as endogenous compounds (e.g., bilirubin-glucuronides), drugs, toxic chemicals, nutraceuticals, and their conjugates, it displays a preference for phase II conjugates. Phenotypically, the most obvious consequence of mutations in ABCC2 that lead to Dubin-Johnson syndrome is conjugate hyperbilirubinemia. ABCC2/Abcc2 harbors multiple binding sites and displays complex transport kinetics.
open_in_new Read the Source
Next: A novel screening strategy to identify ABCB1 substrates and inhibitors
Previous: Ins and outs of the ABCG2 multidrug transporter: An update on in vitro functional assays
